PET/MRI early aftermyocardial infarction: Evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake

European Heart Journal Cardiovascular Imaging

Volumn 16, Issue 6, 2015, Pages 661-669

  Rischpler, Christoph ^a,b   Langwieser, Nicolas ^a   Souvatzoglou, Michael ^a   Batrice, Anja ^a   Van Marwick, Sandra ^a   Snajberk, Julian ^a   Ibrahim, Tareq ^a   Laugwitz, Karl Ludwig ^a,b   Nekolla, Stephan G ^a,b   Schwaiger, Markus ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

FDG; Late gadolinium enhancement; Myocardial infarction; PET MRI; Viability; Wall motion recovery

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOBENATE DIMEGLUMINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE; RADIOPHARMACEUTICAL AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; EVALUATION STUDY; FEASIBILITY STUDY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PET-MRI SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; HEART INFARCTION; IMAGE ENHANCEMENT; MIDDLE AGED; MULTIMODAL IMAGING; PATHOLOGY; PROCEDURES;

ADULT; AGED; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; MYOCARDIAL INFARCTION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84942117049     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu317     Document Type: Article

References (40)

1. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
2. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New Engl J Med 2000;343:1445-53.
3. Schinkel AF, Poldermans D, Elhendy A, Bax JJ. Assessment of myocardial viability in patients with heart failure. J Nucl Med 2007;48:1135-46.
4. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117:103-14.
5. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 1998;98(19 Suppl):II51-6.
6. D'Egidio G, Nichol G, Williams KA, Guo A, Garrard L, deKemp R et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovascular imaging 2009;2: 1060-8.
7. Heyndrickx GR, MillardRW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.
8. Klein C, Nekolla SG, BalbachT, Schnackenburg B, Nagel E, Fleck E et al. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 2004;20:588-93.
9. Klein C, Schmal TR, Nekolla SG, Schnackenburg B, Fleck E, Nagel E. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2007;9:653-8.
10. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-43.
11. Shirasaki H, Nakano A, Uzui H, Yonekura Y, Okazawa H, Ueda T et al. Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction. Eur J Nucl Med Mol Imaging 2006;33:879-86.
12. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
13. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). J Am Med Assoc 1993;269:3015-23.
14. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
15. Whelton PK. Epidemiology of hypertension. Lancet 1994;344:101-6.
16. Torigian DA, Zaidi H, Kwee TC, SabouryB, Udupa JK, ChoZHet al. PET/MR imaging: technical aspects and potential clinical applications. Radiology 2013;267:26-44.
17. Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR Scanner. J Nucl Med 2011;52:1914-22.
18. Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Furst S, Martinez-Moller A et al. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 2012;53:845-55.
19. Souvatzoglou M, Fuerst S, Foerster S, EiberM, Nekolla S, Ziegler S et al. Comparison of simultaneous [18F]FET PET/MR with PET/CT in patients with cerebral tumours. Eur J Nucl Med Mol Imaging 2012;39:S245-6.
20. Souvatzoglou M, Eiber M, Takai T, Fuerst S, Drzezga A, Ziegler S et al. Intergrated simultaneous [C-11]choline PET/MR in patients with prostate cancer. Comparison with PET/CT. Eur J Nucl Med Mol Imaging 2012;39:S254-5.
21. Eiber M, Souvatzoglou M, Geinitz H, Rummeny EJ, Schwaiger M, Beer AJ. First clinical experience in restaging of patients with recurrent prostate cancer by 11C-Choline- PET/MR: comparison with 11C-Choline-PET/CT. Eur J Nucl Med Mol Imaging 2012; 39(Suppl 2):S174.
22. Boehm J, Haas F, Bauernschmitt R, Wagenpfeil S, Voss B, SchwaigerMet al. Impact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization. Int J Cardiovasc Imaging 2010;26: 423-32.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
24. Martinez-Moller A, Souvatzoglou M, Delso G, Bundschuh RA, Chefd'hotel C, Ziegler SI et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 2009;50: 520-6.
25. Nuyts J, Bal G, Kehren F, Fenchel M, Michel C, Watson C. Completion of a truncated attenuation image from the attenuated PET emission data. IEEE Trans Med Imaging 2013;32:237-46.
26. Huber AM, Schoenberg SO, Hayes C, Spannagl B, Engelmann MG, FranzWMet al. Phase-sensitive inversion-recoveryMRimaging in the detectionof myocardial infarction. Radiology 2005;237:854-60.
27. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, LaskeyWK et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
28. Kuhl HP, Lipke CS, Krombach GA, Katoh M, Battenberg TF, Nowak B et al. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 2006;27:846-53.
29. Bove CM, DiMaria JM, Voros S, Conaway MR, Kramer CM. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting-initial experience. Radiology 2006;240:835-41.
30. Schvartzman PR, Srichai MB, Grimm RA, Obuchowski NA, Hammer DF, McCarthy PM et al. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. Am Heart J 2003; 146:535-41.
31. Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schomig A et al. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology 2010; 254:88-97.
32. Nekolla SG, Miethaner C, Nguyen N, Ziegler SI, Schwaiger M. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med 1998;25:1313-21.
33. Castellani M, Colombo A, GiordanoR, Pusineri E, Canzi C, LongariVet al. The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection. J Nucl Med 2010;51:1908-16.
34. Baer FM, Voth E, Deutsch HJ, Schneider CA, Horst M, de Vivie ER et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 1996;28:60-9.
35. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WGet al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003;42:895-901.
36. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-9.
37. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7.
38. Nensa F, Poeppel TD, Beiderwellen K, Schelhorn J, Mahabadi AA, Erbel R et al. Hybrid PET/MR imaging of the heart: feasibility and initial results. Radiology 2013; 268:366-73.
39. Oshinski JN, Delfino JG, Sharma P, Gharib AM, PettigrewRI. Cardiovascular magnetic resonance at 3.0 T: current state of the art. J Cardiovasc Magn Reson 2010;12:55.
40. Huber A, Bauner K, Wintersperger BJ, Reeder SB, Stadie F, Mueller E et al. Phasesensitive inversion recovery (PSIR) single-shot TrueFISP for assessment of myocardial infarction at 3 tesla. Invest Radiol 2006;41:148-53.